1275 York AvenueNew York, NY 10065
Overview of Dr. Ortiz
Dr. Michael Ortiz is a pediatric hematologist/oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and New York-Presbyterian Hospital. He received his medical degree from University of Florida College of Medicine and has been in practice 7 years. He is one of 128 doctors at New York-Presbyterian Hospital and one of 100 doctors at Memorial Sloan Kettering Cancer Center who specialize in Pediatric Hematology & Oncology. He has more than 40 publications and over 500 citings.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2014 - 2017
Children's National HospitalChief Residency, Pediatrics, 2013 - 2014- Children's National HospitalResidency, Pediatrics, 2010 - 2013
University of Florida College of MedicineClass of 2010, M.D.
Certifications & Licensure
FL State Medical License 2023 - Present
NJ State Medical License 2024 - 2025
NY State Medical License 2014 - 2025
DC State Medical License 2010 - 2014
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors Start of enrollment: 2020 Dec 10
Roles: Contact, Principal Investigator
- A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment Start of enrollment: 2021 Jun 09
Roles: Principal Investigator, Contact
- A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors Start of enrollment: 2023 Aug 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Improving global access to genomic profiling in rare pediatric cancers.Sameer Farouk Sait, Tara J O'Donohue, Tejus Bale, Anita Bowman, Katherine Hill
Clinical Cancer Research. 2025-05-20 - 1 citationsHallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers.Daniela Perotti, Maureen J O'Sullivan, Amy L Walz, Jonathan Davick, Reem Al-Saadi
Nature Reviews. Urology. 2025-01-29 - ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial Results.Emily K Slotkin, Audrey Mauguen, Filemon S Dela Cruz, Michael V Ortiz, Viswatej Avutu
JCO Oncology Advances. 2025-01-01
Grant Support
- NCIMemorial Sloan Kettering Cancer Center2017–2020
External Links
- MSK Kidshttps://www.mskcc.org/cancer-care/doctors/michael-ortiz
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
